The Management Team
Mark Busgang: MBA, CEO & President
Mr. Busgang is the President and CEO of Illumisonics Inc. Previously he was the COO of FCM Recycling Inc., responsible for the day to day operations at FCM. Concurrently with his mandate at FCM, Mr. Busgang was President of Busgang Consultants, focused on strategic planning and M&A. From 1998 to 2011 Mr. Busgang was Founder, President and CEO of Warnex Ltd., a Laboratory Services company listed on the TSX. In 1993 Mark co- founded Theratechnologies Inc., a biotechnology company listed on the TSX, and served as Vice–President responsible for commercial operations. Prior to that, he served as president of Pharmetics Ltd, a leading Canadian contract manufacturer of pharmaceutical and nutraceutical products.
Mark has served on the boards of several private and public companies and institutions and charitable organizations. He was a finalist for the Ernst and Young Entrepreneur of the Year award in 2011 and is currently a member of YPO/WPO.
He holds a B. Comm. degree in Accounting from Concordia University in Montreal and an MBA from the Martino School of Business at Fordham University in New York.
John Mackey: MD., Board Member, Medical Chief Officer
John is a medical oncologist and Director, Clinical Trials Unit at the Cross Cancer Institute, and Professor of Oncology, University of Alberta. He is a founder of three companies in the medtech / biotech space, and is Executive Director of Translational Research In Oncology (TRIO), a global clinical trial company with its head office in Edmonton. He directs the clinical development and evaluation of Illumisonics technology.
Bruce Johnson: B.Sc. Board Member
Bruce has been the Chief Executive of a number of companies primarily in the technology sector. He was the co-founder and CEO of Intuit Canada and UK and grew that organization to 700 staff and revenues of around $115M. He currently is active in coaching entrepreneurs and sits on a number of boards including Campbell Scientific Canada, HeadCount Corporation, Visio Media Inc., Social Asset Management Inc., Rehabtronics Inc., and the Alberta Machine Intelligence Institute.
Parsin Haji Reza: PhD, Co-founder, Chairman of the Board, Scientific Chief Officer
Parsin has discovered and pioneered the PARS imaging effect and co-founded illumiSonics in November 2014. Parsin is an Assistant Professor at the University of Waterloo with more than 10 years experience in optics and biomedical engineering. He was the CEO of illumiSonics until March 2018. Currently, he chairs the illumiSonics board and oversees the direction and vision for illumiSonics. Parsin has published more than 25 peer reviewed papers in optics and biomedical Engineering. He has received several international and national awards and scholarships for his scientific and entrepreneurial achievements.